Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report.

The article focuses on ulcerative lymphomatoid papulosis (LyP) as a rare immune-related adverse event following immune checkpoint inhibitor (ICI) therapy and autologous stem cell transplant (autoSCT) in a patient with recurrent Hodgkin lymphoma. Topics include the rarity of LyP as an ICI-induced adverse event, the clinical presentation and histopathological features of ulcerative LyP, and the challenges in diagnosis and management of LyP in patients treated with ICIs and autoSCT.